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Despite having the ability for in vivo synthesis of long-chain omega-3 
polyunsaturated fatty acids (LC n-3 PUFA), evidence suggests that our 
capacity for synthesis is limited1. As a consequence, we need to rely on 
dietary sources of LC n-3 PUFA’s, particularly eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA). 
 
EPA and DHA are key nutrients for development2 and the moderation of 
inflammatory responses implicated in the mechanism for cardiovascular 
disease3. 
 
Very little data is available on current UK intakes of EPA and DHA. 
Methodology to comprehensively establish intakes of EPA and DHA  
involves analysis of food intake over a period of at least fourteen days4.  
This is due to the fact that sources of EPA and DHA in the diet are limited 
to very few, infrequently consumed foods, including oily fish and some 
specially fortified products such as milk, eggs and yogurts. 
 
There is also a paucity of data about how intakes relate to the status of LC 
n-3 PUFA’s in the body. Establishing LC n-3 PUFA status usually involves 
invasive methodology to samples lipid levels in various fractions of the 
blood and plasma5. 
 
Developing methodology for quick and reliable assessment  of DHA and 
EPA intakes has many valuable applications in public health research and 
is also likely to facilitate the investigation of vulnerable, hard to reach 
populations.  Combining such methodology with a minimally invasive 
assessment of status allows the potential impact of health education 
initiatives to be assessed. 
 
Introduction Project Outcomes 
Twenty subjects were recruited to the study (16 females) with an 
average age of 30.4 years (range 19 – 47 years). Seventeen of the 
participants (85%) were considered fish-eaters. 
 
Average intakes of EPA, DHA and total LC n-3 PUFA (EPA + DHA) 
as assessed by the FFQ and the 14 day diet record are presented 
in Table 1. 
The aim of this study was to validate a minimally invasive method of 
assessing dietary intakes and correlate this with whole blood levels 
of LC n-3 PUFA. 
 
Intakes of EPA and DHA were assessed using: 
 a targeted food frequency questionnaire (FFQ), which had 
previously been developed for use in healthy adults6,7. 
 a 14-day diet record of all foods and beverages consumed 
 
Whole blood fatty acid levels were assessed using the Rapid Omega 
Test8, which involves collecting a finger prick blood sample on a 
Whatman 903® neonatal std card and subsequent analysis of fatty 
methyl esters by gas-liquid chromatography.  This technique has 
previously been validated against red blood cell polar lipid fatty 
acids8. 
Study Design 
Assessment 
method 
 
EPA 
(g/day) 
DHA 
(g/day) 
LC n-3 PUFA 
(g/day) 
FFQ 0.16 ± 0.13 0.23 ± 0.21 0.40 ± 0.34 
14 day diet 
record 
0.15 ± 0.13 0.27 ± 0.23 0.42 ± 0.35 
Table 1: Average intakes of EPA, DHA and total LC n-3 PUFA 
Despite mean intakes of LC n-3 PUFA being close to current UK 
recommendations of 0.45mg/d (SACN, 2004),  only 7 participants 
(35%) met or exceeded recommended intakes by either method. 
Only 5 of these participants, however, were assessed as meeting 
recommended intakes by both methods of assessment. 
 
 
Study design 
14-day diet record 
FFQ 
Rapid Omega 
Day 1 Day 14 
Intakes were assessed against UK recommendations9. Levels of  
agreement between intake assessment methods for EPA, DHA and 
total n-3 PUFA were investigated using Bland-Altman analysis. 
Correlation between whole blood levels, measured using the Rapid 
Omega test, and dietary intakes were also investigated. 
Good agreement between 
FFQ and diet record 
Bland Altman analysis showed good agreement between the FFQ 
and the 14-day diet records in assessing intakes of EPA (Fig. 1) 
and DHA (Fig. 2).  For EPA all mean differences were within the 
limits of agreement, and the results indicated that the FFQ 
underestimated intakes by a mean of 10mg/d (Fig. 1). 
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Fig 1: Bland-Altman plot showing the level of agreement between the 
 FFQ and diet record results for average daily intake of EPA (g/d) 
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Conclusions 
• Intakes of LC n-3 PUFA in 65% of this adult population were 
below current UK recommendations, which causes concern in 
relation to the risk of cardiovascular disease   
 
• The targeted FFQ is a valid method for estimating dietary 
intakes of EPA and DHA, which is quick to complete. 
 
• Intakes of EPA and DHA correlated with whole blood 
percentage fatty acid levels measured from a finger prick 
blood sample using the Rapid Omega test. 
 
• The FFQ and Rapid Omega test provide minimally invasive 
methods of measuring intakes of LC n-3 PUFA and the 
corresponding whole blood fatty acid status. 
 
• In combination, these methods could be employed to assess 
LC n-3 PUFA intakes in a wide range of population groups in 
response to health education initiatives.  
Significant correlation was shown between intakes of EPA (Fig. 4) 
and DHA (Fig. 5), assessed using the FFQ, against whole blood 
levels (% total fatty acids). 
Correlation between FFQ 
intake and whole blood 
fatty acid levels 
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Fig 2: Bland-Altman plot showing the level of agreement between the  
FFQ and diet record results for average daily intake of DHA (g/d) 
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Fig 4: Association between 
daily EPA Intakes  (FFQ, g/d) 
and EPA in whole blood 
(% total fatty acids) 
 
r2=0.3, p=0.013 
DHA present in whole blood 
Fig 5: Association between 
daily DHA intake (FFQ, g/d) 
and DHA in whole blood 
(% total fatty acids) 
 
r2=0.3, p=0.015 
For DHA the majority of mean differences were within the limits of 
agreement, except for one participant, and the results indicated that the 
FFQ overestimated intakes by a mean of 30mg/d (Fig. 2).   
For total LC n-3 PUFA the majority of mean differences were within the 
limits of agreement, except one, and the results indicated that the FFQ 
overestimated intakes by a mean of 20mg/d (Fig. 3).   
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Fig 3: Bland-Altman plot showing the level of agreement between the  
FFQ and diet record results for daily intake of total LC n-3 PUFA (g/d) 
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